Meeting
2023 ASCO Genitourinary Cancers Symposium
Comparative transcriptomic analysis of DNA-damage response and androgen receptor pathway activity between biopsy and radical prostatectomy specimens before and after pre-operative real-time MRI-guided stereotactic body radiotherapy.
Authors
Himanshu Nagar
Weill Cornell Medicine, New York, NY
Himanshu Nagar , Alicia Dillard , Alexander K. Hakansson , Yang Liu , Elai Davicioni , Sydney Wolfe , Jim C. Hu , Douglas Scherr , Francesca Khani , Ariel E. E. Marciscano , Christopher Barbieri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 375)
DOI
10.1200/JCO.2023.41.6_suppl.375
Abstract #
375
Poster Bd #
N13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of neoadjuvant stereotactic body radiation therapy (SBRT) on the immune microenvironment of high-risk localized prostate cancer in paired transcriptomic analysis of pretreatment biopsy and irradiated prostatectomy specimens.
First Author: Ariel E. E. Marciscano
Poster
2019 Genitourinary Cancers Symposium
Preoperative radiotherapy for high-risk prostate cancer (PORT-PC) trial.
First Author: Himanshu Nagar
Poster
2017 ASCO Annual Meeting
A 17-gene panel for prediction of adverse surgical pathology in the setting of MRI-guided prostate biopsy.
First Author: Amirali Salmasi
Poster
2017 Genitourinary Cancers Symposium
Relationships between an androgen receptor output signature (ARoS), AR expression, and poor prostate cancer prognosis in RP tissues.
First Author: Mohammed Alshalalfa